−463 G/A Myeloperoxidase Promoter Polymorphism Is Associated with Clinical Manifestations and the Course of Disease in MPO-ANCA-Associated Vasculitis
- 31 May 2002
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 103 (2) , 154-160
- https://doi.org/10.1006/clim.2002.5206
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Myeloperoxidase – 463A variant reduces benzo[a]pyrene diol epoxide DNA adducts in skin of coal tar treated patientsCarcinogenesis: Integrative Cancer Research, 2001
- Low Expression Myeloperoxidase Genotype Negatively Associated with Helicobacter pylori InfectionJapanese Journal of Cancer Research, 2001
- Proteinase 3 gene polymorphisms and Wegener's granulomatosisKidney International, 2000
- The Association of CD18 Alleles with Anti-myeloperoxidase Subtypes of ANCA-Associated Systemic VasculitidesClinical Immunology, 2000
- Myeloperoxidase Polymorphism Is Associated with Gender Specific Risk for Alzheimer's DiseaseExperimental Neurology, 1999
- Animal models of anti-neutrophil cytoplasmic antibody associated vasculitisKidney International, 1998
- Nomenclature of Systemic VasculitidesArthritis & Rheumatism, 1994
- Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cellsKidney International, 1992
- Autoantibodies against myeloid lysosomal enzymes in crescentic glomerulonephritisKidney International, 1990
- Tissue Destruction by NeutrophilsNew England Journal of Medicine, 1989